Published: 29 March 2024
Author(s): Maximilian Boesch, Florent Baty, Frank Rassouli, Martin H. Brutsche
Issue: May 2024
Section: Ideas and Opinions

An interesting session during a major scientific conference attended by the authors in fall 2023 discussed the concept of disease modification (DM). It became evident that DM is something that medical treatments should achieve and there was also a clear demarcation from symptomatic(-only) treatments. An exact definition of disease-modifying drugs (DMDs) was not given but it was argued that DMDs should at least fulfill the following two criteria: (i) improvement of patient outcome and (ii) tackling of the underlying pathophysiology through a causal therapeutic approach.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.